On Jun 27, 2018 Vbi Vaccines Inc – Ordinary Shares (NASDAQ:VBIV) Shorts Increased By 11.31%

June 27, 2018 - By Nicole Mills

VBI Vaccines Inc. (NASDAQ:VBIV) Corporate Logo

It was noted an increase on Vbi Vaccines Inc – Ordinary Shares (NASDAQ:VBIV)’s short interest with 11.31%. FINRA announced short interest of VBIV’s total 820,900 shares. That’s 11.31% up from 737,500 shares. 6 days will cost VBIV with 131,400 average volume to restore its former position. Vbi Vaccines Inc – Ordinary Shares’s short interest float is 2.14%.

VBIV is hitting $2.85 during the last trading session, after decreased 2.73%.VBI Vaccines Inc. has volume of 105,434 shares. Since June 27, 2017 VBIV has declined 26.86% and is downtrending. VBIV underperformed the S&P500 by 39.43%.

VBI Vaccines Inc., a commercial stage biopharmaceutical company, develops vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally.The company has $183.02 million market cap. It is developing eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccine technology, a vaccine formulation technology that enables the thermostabilization of vaccines through a proprietary formulation and freeze-drying process.Currently it has negative earnings. The firm also offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborn infants.

There’s a significant VBI Vaccines Inc. (NASDAQ:VBIV) news published by Globenewswire.com. It’s an item titled: “VBI Vaccines to Present at 2018 JMP Securities Life Sciences Conference” on June 19, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.